Evidence map›Paper›PMID 29802369›Full record

ArticleScientific reports2018

Effects of Low-level Brodifacoum Exposure on the Feline Immune Response.

Jennifer H Kopanke, Katherine E Horak, Esther Musselman, Craig A Miller, Kristine Bennett, Christine S Olver, Steven F Volker, Sue VandeWoude, Sarah N Bevins

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jennifer H KopankeColorado State University, Department of Microbiology, Immunology, and Pathology, Fort Collins, 80523, USA. jennifer.kopanke@colostate.edu.
Katherine E HorakUSDA-APHIS, National Wildlife Research Center, Fort Collins, 80521, USA.
Esther MusselmanColorado State University, Department of Microbiology, Immunology, and Pathology, Fort Collins, 80523, USA.
Craig A MillerColorado State University, Department of Microbiology, Immunology, and Pathology, Fort Collins, 80523, USA.
Kristine BennettColorado State University, Department of Microbiology, Immunology, and Pathology, Fort Collins, 80523, USA.ORCID 0000-0002-6206-0792
Christine S OlverColorado State University, Department of Microbiology, Immunology, and Pathology, Fort Collins, 80523, USA.
Steven F VolkerUSDA-APHIS, National Wildlife Research Center, Fort Collins, 80521, USA.
Sue VandeWoudeColorado State University, Department of Microbiology, Immunology, and Pathology, Fort Collins, 80523, USA.
Sarah N BevinsUSDA-APHIS, National Wildlife Research Center, Fort Collins, 80521, USA. sarah.n.bevins@aphis.usda.gov.
Colorado State University · USAnimal and Plant Health Inspection Service · US

Funding

Biomedical Research Training for VeterinariansT32OD010437 · OD · COLORADO STATE UNIVERSITY · PI Gregg A Dean, KELLY S SANTANGELO · 2012 to 2026
$6.2M
NIH HHS T32 OD010437
6 · The paper itself

Abstract

Anticoagulant rodenticides have been implicated as a potential inciting factor in the development of mange in wild felids, but a causative association between anticoagulant rodenticide exposure and immune suppression has not been established. Specific-pathogen-free domestic cats were exposed to brodifacoum over a 6-week period to determine whether chronic, low-level exposure altered the feline immune response. Cats were vaccinated with irrelevant antigens at different points during the course of the experiment to assess recall and direct immune responses. Measures of immune response included delayed-type hypersensitivity tests and cell proliferation assays. IgE and antigen-specific antibodies were quantified via ELISA assays, and cytokine induction following exposure to vaccine antigens was also analyzed. While cats had marked levels of brodifacoum present in blood during the study, no cats developed coagulopathies or hematologic abnormalities. Brodifacoum-exposed cats had transient, statistically significant decreases in the production of certain cytokines, but all other measures of immune function remained unaffected throughout the study period. This study indicates that cats may be more resistant to clinical effects of brodifacoum exposure than other species and suggests that the gross impacts of environmentally realistic brodifacoum exposure on humoral and cell-mediated immunity against foreign antigen exposures in domestic cats are minimal.

Indexed as

4-HydroxycoumarinsAnimalsCatsCytokinesDose-Response Relationship, DrugGene Expression RegulationHealthHypersensitivity, DelayedImmunityRodenticidesTime Factors4-HydroxycoumarinsbromfenacoumCytokinesRodenticides

Identifiers

PMID29802369
PMCPMC5970145
OpenAlexW2806840793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.